Tvardi Therapeutics, Inc.
General ticker "TVRD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $209.7M (TTM average)
Tvardi Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -22.1%.
Estimated limits based on current volatility of 3.5%: low 3.86$, high 4.14$
Short-term TVRD quotes
Long-term TVRD plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $41.87MM | $20.97MM | $7.14MM |
| Operating Expenses | $129.40MM | $142.46MM | $62.92MM |
| Operating Income | $-87.53MM | $-121.50MM | $-55.78MM |
| Non-Operating Income | $2.06MM | $2.98MM | $-15.48MM |
| Interest Expense | $0.00MM | $0.00MM | $8.47MM |
| R&D Expense | $91.76MM | $108.38MM | $32.76MM |
| Income(Loss) | $-85.47MM | $-118.51MM | $-71.27MM |
| Taxes | $0.00MM | $0.00MM | $-0.40MM |
| Profit(Loss)* | $-20.54MM | $-17.35MM | $-70.87MM |
| Stockholders Equity | $-45.05MM | $-62.06MM | $-4.59MM |
| Inventory | $0.00MM | $0.00MM | $0.90MM |
| Assets | $45.10MM | $27.00MM | $43.83MM |
| Operating Cash Flow | $-17.87MM | $-21.04MM | $-60.92MM |
| Capital expenditure | $0.05MM | $2.38MM | $1.05MM |
| Investing Cash Flow | $-22.00MM | $22.47MM | $48.74MM |
| Financing Cash Flow | $0.00MM | $0.00MM | $-3.60MM |
| Earnings Per Share** | $-2.20 | $-1.85 | $-46.60 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.